Literature DB >> 6247492

Antibiotic inhibition of protease production by Pseudomonas aeruginosa.

A M Shibl, I A Al-Sowaygh.   

Abstract

The effects of tetracycline, chloramphenicol and polymyxin B on growth and protease production by Pseudomonas aeruginosa were studied. Tetracycline inhibited protease production at concentrations much lower than those required to cause growth inhibition; the effect was not due to inhibition of protease activity by the antibiotic. In contrast, chloramphenicol and polymyxin B inhibted protease production in direct proportion to the inhibition of growth. Lysozyme-release experiments with washed tetracycline-treated cells indicated that the protease did not accumulate intracellularly. The protease-inhibiting effect of tetracycline might have therapeutic significance if it were found to occur in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247492     DOI: 10.1099/00222615-13-2-345

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Isolation of a potent antibiotic producer bacterium, especially against MRSA, from northern region of the Persian Gulf.

Authors:  Esmaeil Darabpour; Mohammad Roayaei Ardakani; Hossein Motamedi; Mohammad Taghi Ronagh
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus.

Authors:  S Herbert; P Barry; R P Novick
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Alterations in Pseudomonas aeruginosa exoproducts by sub-MICs of some antibiotics.

Authors:  A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

4.  Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.

Authors:  K Grimwood; M To; H R Rabin; D E Woods
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.938

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.